1.26
price down icon0.79%   -0.01
after-market Handel nachbörslich: 1.76 0.50 +39.68%
loading

Finanzdaten der Biocardia Inc-Aktie (BCDA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Selling, General, and Administrative
19.18%
0.552
0.683 1.196 - -
Costs And Expenses
27.45%
1.488
2.051 2.726 2.321 1.756
Operating Income/Loss
27.45%
-1.488
-2.051 -2.726 -2.321 -1.756
Nonoperating Income/Loss
150.00%
0.005
0.002 0.014 0.025 0.019
Income/Loss From Continuing Operations Before Tax
27.38%
-1.488
-2.049 -2.712 -2.321 -1.756
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.62%
-1.483
-2.049 -2.712 -2.296 -1.737
Net Income/Loss
27.62%
-1.483
-2.049 -2.712 -2.296 -1.737
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24.07%
6.2778
5.0597 4.6358 0.6146 2.8275
Basic Earnings Per Share
40.00%
-0.24
-0.40 -0.59 -0.25 -0.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):